Sandu Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 764862, "name": "Sandu Pharma.", "stock_name": "Sandu Pharma.", "full_name": "Sandu Pharmaceuticals Ltd", "name_url": "stocks-analysis/sandu-pharma", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "39.48", "chg": -0.32, "chgp": "-0.8%", "dir": -1, "prev_price": "39.80", "mcapval": "39.00 Cr", "mcap": "Micro Cap", "scripcode": 524703, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 49, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE751D01014", "curr_date": "Aug 11, 01:26 PM", "curr_time": "13:32 PM", "last_traded_at": "Aug 11, 01:26 PM IST", "bse_nse_vol": "939 ", "exc_status": "Active", "traded_date": "Aug 11, 2026", "traded_date_str": "2026 08 11", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sandu-pharma-764862-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Sandu Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4146177", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanduPharmaceut_valuationdot_4146177.png", "date": "2026-08-11 08:01:29", "description": "Sandu Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting evolving market perceptions amid mixed financial metrics and sector comparisons. This article analyses the recent changes in key valuation ratios, their implications for investors, and how Sandu Pharma stacks up against its peers and broader market benchmarks." }, { "title": "Sandu Pharmaceuticals Gains 1.46%: 2 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-gains-146-2-key-factors-driving-the-week-4143405", "imagepath": "", "date": "2026-08-08 15:10:34", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> Stock surged 4.23% to Rs.40.69 on strong volume</p>\n <p><strong>5 Aug:</strong> Valuation metrics improved, signalling renewed price attractiveness</p>\n <p><strong>6 Aug:</strong> Stock declined 3.32% amid bearish technical signals</p>\n <p><strong>7 Aug:</strong> Downgrade to Strong Sell rating announced; stock closed at Rs.39.61 (+2.94%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.39.04</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</d..." }, { "title": "Sandu Pharmaceuticals Downgraded to Strong Sell Amid Technical and Financial Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-downgraded-to-strong-sell-amid-technical-and-financial-concerns-4141154", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanduPharmaceut_mojoScore_4141154.png", "date": "2026-08-07 08:12:27", "description": "Sandu Pharmaceuticals Ltd has seen its investment rating downgraded from Sell to Strong Sell, reflecting deteriorating technical indicators and persistent financial underperformance. Despite an attractive valuation, the company’s weak fundamentals and bearish technical trends have raised concerns among investors, prompting a reassessment of its market prospects." }, { "title": "Sandu Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4136832", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SanduPharmaceut_valuationdot_4136832.png", "date": "2026-08-05 08:02:20", "description": "Sandu Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a nuanced change in price attractiveness despite recent share price declines and mixed performance against benchmark indices. This article analyses the evolving valuation metrics, peer comparisons, and market returns to provide a comprehensive view for investors considering this micro-cap pharmaceutical player." }, { "title": "When is the next results date for Sandu Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sandu-pharmaceuticals-ltd-4136326", "imagepath": "", "date": "2026-08-04 23:18:24", "description": "The next results date for Sandu Pharmaceuticals Ltd is scheduled for 11 August 2026...." }, { "title": "Sandu Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-is-rated-sell-4128375", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SanduPharmaceut_mojoScore_4128375.png", "date": "2026-07-30 10:11:27", "description": "Sandu Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Sandu Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-is-rated-sell-4106316", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SanduPharmaceut_mojoScore_4106316.png", "date": "2026-07-17 10:10:04", "description": "Sandu Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Sandu Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-is-rated-sell-4081607", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SanduPharmaceut_mojoScore_4081607.png", "date": "2026-07-01 10:10:03", "description": "Sandu Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Sandu Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-is-rated-sell-4061151", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SanduPharmaceut_mojoScore_4061151.png", "date": "2026-06-18 10:10:04", "description": "Sandu Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 18 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook." } ], "total": 114, "sid": "764862", "stock_news_url": "https://www.marketsmojo.com/news/sandu-pharmaceuticals-764862" }, "announcements": [ { "caption": "Board Meeting Intimation for To Consider And Approve The Standalone Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026.", "datetime": "03-Aug-2026", "details": "Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve 1.To consider and approve the Standalone Unaudited Financial Results of the Company for the quarter ended 30th June 2026. 2.To consider any other matter with the permission of the Chair", "source": "BSE" }, { "caption": "Announcement Under Regulation 30-Reconstitution Of Committees Of Board-Audit/Nomination/Stakeholders", "datetime": "11-Jul-2026", "details": "Reconstitution of Committees of Board-Audit/Nomination/Stakeholders", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 11.07.2026", "datetime": "11-Jul-2026", "details": "Outcome of the Board Meeting dated 11.07.2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "(11 Aug 2026)" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Sandu Pharmaceuticals Ltd has declared <strong>8%</strong> dividend, ex-date: 18 Sep 25", "dt": "2025-09-18", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: Stock surged 4.23% to Rs.40.69 on strong volume

5 Aug: Valuation metrics improved, signalling renewed price attractiveness

6 Aug: Stock declined 3.32% amid bearish technical signals

7 Aug: Downgrade to Strong Sell rating announced; stock closed at Rs.39.61 (+2.94%)

Week Open

Rs.39.04

Week CloseRead full news article

Sandu Pharmaceuticals Downgraded to Strong Sell Amid Technical and Financial Concerns

2026-08-07 08:12:27

Sandu Pharmaceuticals Ltd has seen its investment rating downgraded from Sell to Strong Sell, reflecting deteriorating technical indicators and persistent financial underperformance. Despite an attractive valuation, the company’s weak fundamentals and bearish technical trends have raised concerns among investors, prompting a reassessment of its market prospects.

Read full news article

Sandu Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-08-05 08:02:20

Sandu Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a nuanced change in price attractiveness despite recent share price declines and mixed performance against benchmark indices. This article analyses the evolving valuation metrics, peer comparisons, and market returns to provide a comprehensive view for investors considering this micro-cap pharmaceutical player.

Read full news article

When is the next results date for Sandu Pharmaceuticals Ltd?

2026-08-04 23:18:24

The next results date for Sandu Pharmaceuticals Ltd is scheduled for 11 August 2026....

Read full news article

Sandu Pharmaceuticals Ltd is Rated Sell

2026-07-30 10:11:27

Sandu Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sandu Pharmaceuticals Ltd is Rated Sell

2026-07-17 10:10:04

Sandu Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sandu Pharmaceuticals Ltd is Rated Sell

2026-07-01 10:10:03

Sandu Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sandu Pharmaceuticals Ltd is Rated Sell

2026-06-18 10:10:04

Sandu Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 18 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article